Assignee
REPONEX PHARMACEUTICALS AS
DK·2 granted patents·5 pending applications·0 citations·filing 2015–2021
Top patents by PatentIndex Score
7 records- 0161US2022218792A1Compositions to promote the healing of skin ulcers and woundsREPONEX PHARMACEUTICALS AS·Filed 2021·Application pending·0 cites
- 0251US2020254062A1Compositions to promote the healing of skin ulcers and woundsREPONEX PHARMACEUTICALS AS·Filed 2019·Application pending·0 cites
- 0349US11426449B2Methods and compositions for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapyREPONEX PHARMACEUTICALS AS·Filed 2017·Granted Aug 30, 2022·0 cites·4 claims
- 0436US2022175885A1Targeting biological agents to mucosal defects of the gastrointestinal tractREPONEX PHARMACEUTICALS AS·Filed 2020·Application pending·0 cites
- 0536US2021060038A1Compositions for eliminating bacterial promotors of colorectal cancer by intraluminal applicationREPONEX PHARMACEUTICALS AS·Filed 2019·Application pending·0 cites
- 0634US10105415B2Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel diseaseREPONEX PHARMACEUTICALS AS·Filed 2015·Granted Oct 23, 2018·0 cites·10 claims
- 0734US2022211667A1Composition for the intraperitoneal treatment of secondary bacterial peritonitis with reduction of complicationsREPONEX PHARMACEUTICALS AS·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when REPONEX PHARMACEUTICALS AS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →